<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05034601</url>
  </required_header>
  <id_info>
    <org_study_id>2021-866</org_study_id>
    <nct_id>NCT05034601</nct_id>
  </id_info>
  <brief_title>ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure</brief_title>
  <official_title>Comparison of Erector Spinae Plane and Paravertebral Nerve Blocks for Postoperative Analgesia in Children After the Nuss Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized double-blind non-inferiority trial designed to test the&#xD;
      hypothesis that erector spinae plane block (ESPB) is non-inferior to thoracic paravertebral&#xD;
      block (TPVB) in postoperative pain control after pectus excavatum repair.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 25, 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores at rest at 24 hours postoperatively</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Pain scores will be recorded using the Numeric Rating Scale (NRS) scores (0-10).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The pain degree at rest and after movement or coughing(dynamic)</measure>
    <time_frame>at 3, 6, 12, 24, and 48 hours after surgery</time_frame>
    <description>The pain degree at rest and after movement or coughing at 3, 6, 12, 24, and 48 hours after surgery respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total rescue morphine-equivalent consumption per weight</measure>
    <time_frame>at 24 and 48 hours after surgery</time_frame>
    <description>total rescue morphine-equivalent consumption per weight at predetermined time intervals (24 and 48 hours) after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergence agitation at 5, 15, 30 min after extubation</measure>
    <time_frame>at 5, 15, 30 min after extubation</time_frame>
    <description>Emergence agitation will be registered using pediatric anesthesia emergence delirium (PAED) at 5, 15, 30 min after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dosage of intraoperative sufentanil and remifentanil</measure>
    <time_frame>during surgery</time_frame>
    <description>Total dosage of intraoperative sufentanil and remifentanil per weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time to first analgesia request</measure>
    <time_frame>within the 3 days after surgery</time_frame>
    <description>Time from operation to first rescue analgesia request</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time to first mobilization</measure>
    <time_frame>within the 3 days after surgery</time_frame>
    <description>Time from operation to ambulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>within the 5 days after surgery</time_frame>
    <description>Side effects such as pneumothorax, local anesthetic toxicity, postoperative nausea and vomiting</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Nerve Block</condition>
  <condition>Analgesia</condition>
  <condition>Pectus Excavatum</condition>
  <arm_group>
    <arm_group_label>ESPB group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.25% ropivacaine 0.5 ml/kg is injected at the fascial plane deep to the erector spinae muscle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TPVB group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.25% ropivacaine 0.5 ml/kg is injected into the thoracic paravertebral space (T5) using TPVB approach.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ESPB group</intervention_name>
    <description>A 21-gauge 100-mm needle will be inserted into the fascial layer beneath the iliocostalis, longissimus, and spinalis muscles. A bolus of 0.25% ropivacaine 0.5 ml/kg will be injected into the fascial layer. Contralateral ESPB will be performed similarly.</description>
    <arm_group_label>ESPB group</arm_group_label>
    <other_name>Erector spinae plane block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TPVB group</intervention_name>
    <description>A 21-gauge 100-mm insulated needle will be inserted into the paravertebral space via an in-plane parasagittal approach. After perforating the costotransverse ligament, 0.25% ropivacaine 0.5 ml/kg will be injected. Anterior movement of the pleura indicated the appropriate spread of the local anesthetics in the paravertebral space. The process will be repeated on the contralateral side.</description>
    <arm_group_label>TPVB group</arm_group_label>
    <other_name>Thoracic paravertebral block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 4 to 18 years Scheduled for elective Nuss surgery Written informed consent&#xD;
             is obtained from parents of each patient.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coagulation dysfunction. American Society of Anesthesiologists Physical Status 4 or 5.&#xD;
             Allergy to study medication. Local infection at the site of injection or systemic&#xD;
             infection. Inability to understand Chinese.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin Liu</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology, West China Hospital, Sichuan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jing Yang, MD</last_name>
    <phone>+86- 18980602269</phone>
    <email>yangjing@wchscu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology, West China Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Yang, MD</last_name>
      <phone>+86- 18980602269</phone>
      <email>yangjing@wchscu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 21, 2021</study_first_submitted>
  <study_first_submitted_qc>September 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Hospital</investigator_affiliation>
    <investigator_full_name>Min Xu</investigator_full_name>
    <investigator_title>Department of Anesthesiology, West China Hospital, Sichuan University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Funnel Chest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

